These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 16260059
21. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets. Uhumwangho MU, Okor RS. Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417 [Abstract] [Full Text] [Related]
25. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. Kuno Y, Kojima M, Ando S, Nakagami H. J Control Release; 2005 Jun 20; 105(1-2):16-22. PubMed ID: 15955365 [Abstract] [Full Text] [Related]
26. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation. Suñé-Negre JM, Pérez-Lozano P, Miñarro M, Roig M, Fuster R, Hernández C, Ruhí R, García-Montoya E, Ticó JR. Eur J Pharm Biopharm; 2008 Aug 20; 69(3):1029-39. PubMed ID: 18367387 [Abstract] [Full Text] [Related]
27. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 2: Comparative self-binding properties. Asker AF, Saied KM, Abdel-Khalek MM. Pharmazie; 1975 Apr 20; 30(4):236-8. PubMed ID: 1153489 [Abstract] [Full Text] [Related]
28. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: physicochemical and technological characterisation. Marinich JA, Ferrero C, Jiménez-Castellanos MR. Eur J Pharm Biopharm; 2009 May 20; 72(1):138-47. PubMed ID: 19146956 [Abstract] [Full Text] [Related]
29. Effects of drying technique on extrusion-spheronisation granules and tablet properties. Song B, Rough SL, Wilson DI. Int J Pharm; 2007 Mar 06; 332(1-2):38-44. PubMed ID: 17071030 [Abstract] [Full Text] [Related]
30. Chemometric evaluation of pharmaceutical properties of antipyrine granules by near-infrared spectroscopy. Otsuka M, Mouri Y, Matsuda Y. AAPS PharmSciTech; 2003 Mar 06; 4(3):E47. PubMed ID: 14621979 [Abstract] [Full Text] [Related]
31. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C. Eur J Pharm Biopharm; 2008 Sep 06; 70(1):302-12. PubMed ID: 18579353 [Abstract] [Full Text] [Related]
32. Formulation design of a novel fast-disintegrating tablet. Mizumoto T, Masuda Y, Yamamoto T, Yonemochi E, Terada K. Int J Pharm; 2005 Dec 08; 306(1-2):83-90. PubMed ID: 16257154 [Abstract] [Full Text] [Related]
33. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets. Alsarra IA, El-Bagory I, Bayomi MA. Drug Dev Ind Pharm; 2005 May 08; 31(4-5):385-95. PubMed ID: 16093204 [Abstract] [Full Text] [Related]
34. Investigating the fundamental effects of binders on pharmaceutical tablet performance. Joneja SK, Harcum WW, Skinner GW, Barnum PE, Guo JH. Drug Dev Ind Pharm; 1999 Oct 08; 25(10):1129-35. PubMed ID: 10529894 [Abstract] [Full Text] [Related]
35. Ocimum Sanctum seeds, a natural superdisintegrant: formulation and evaluation of fast melt tablets of nimesulide. Malik K, Arora G, Singh I. Polim Med; 2012 Oct 08; 42(1):49-59. PubMed ID: 22783733 [Abstract] [Full Text] [Related]
36. Effects of the diluent type on compressional characteristics of the mixed stem bark extract of Anogeissus leiocarpus and Prosopis africana tablet formulation. Isimi CY, Nasipuri RN, Ojile JB, Ibrahim YK, Emeje M. Acta Pharm; 2003 Mar 08; 53(1):49-56. PubMed ID: 14769252 [Abstract] [Full Text] [Related]
37. Beta-cyclodextrin as a direct compression excipient compared to conventional ones. Saleh SI. J Pharm Belg; 1993 Mar 08; 48(5):371-7. PubMed ID: 8120790 [Abstract] [Full Text] [Related]
38. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets. Aly SA, Udeala OK. Pharmazie; 1988 Mar 08; 43(3):188-90. PubMed ID: 3380861 [Abstract] [Full Text] [Related]
39. Formulation and evaluation of dried yeast tablets using different techniques. Al-Mohizea AM, Ahmed MO, Al-jenoobi FI, Mahrous GM, Abdel-Rahman AA. Eur J Pharm Biopharm; 2007 Aug 08; 67(1):253-9. PubMed ID: 17270410 [Abstract] [Full Text] [Related]
40. Assessment of Albizia zygia gum as a binding agent in tablet formulations. Odeku OA. Acta Pharm; 2005 Sep 08; 55(3):263-76. PubMed ID: 16375837 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]